Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Praxis Precision Medicines, Inc. (PRAX)

Compare
29.74
+1.27
+(4.46%)
At close: 4:00:00 PM EDT
29.74
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
8,553
8,553
2,447
--
--
Operating Expense
208,718
208,718
128,820
214,986
167,332
Operating Income
-200,165
-200,165
-126,373
-214,986
-167,332
Other Income Expense
17,346
17,346
3,096
957
271
Pretax Income
-182,819
-182,819
-123,277
-214,029
-167,061
Net Income Common Stockholders
-182,819
-182,819
-123,277
-214,029
-167,061
Diluted NI Available to Com Stockholders
-182,819
-182,819
-123,277
-214,029
-167,061
Basic EPS
-10.21
--
-18.69
-69.60
-59.10
Diluted EPS
-10.21
--
-18.69
-69.60
-59.10
Basic Average Shares
17,906.79
--
6,594.32
3,073.12
2,830.27
Diluted Average Shares
17,906.79
--
6,594.32
3,073.12
2,830.27
Total Operating Income as Reported
-200,165
-200,165
-126,373
-214,986
-167,332
Total Expenses
208,718
208,718
128,820
214,986
167,332
Net Income from Continuing & Discontinued Operation
-182,819
-182,819
-123,277
-214,029
-167,061
Normalized Income
-182,819
-182,819
-123,277
-214,029
-167,061
EBIT
-200,165
-200,165
-126,373
-214,986
-167,332
EBITDA
-199,807
-199,807
-125,941
-214,567
-167,150
Reconciled Depreciation
358
358
432
419
182
Net Income from Continuing Operation Net Minority Interest
-182,819
-182,819
-123,277
-214,029
-167,061
Normalized EBITDA
-199,807
-199,807
-125,941
-214,567
-167,150
12/31/2021 - 10/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYRE Spyre Therapeutics, Inc.
12.22
+2.43%
 
VRDN Viridian Therapeutics, Inc.
12.02
+5.35%
 
STOK Stoke Therapeutics, Inc.
7.02
+7.67%
 
DYN Dyne Therapeutics, Inc.
7.04
+0.86%
 
EWTX Edgewise Therapeutics, Inc.
11.42
-1.30%
 
MLTX MoonLake Immunotherapeutics
34.90
+2.74%
 
TRVI Trevi Therapeutics, Inc.
5.56
+5.30%
 
XNCR Xencor, Inc.
8.54
+7.83%
 
NRIX Nurix Therapeutics, Inc.
9.14
+3.75%
 
KYMR Kymera Therapeutics, Inc.
24.12
+7.68%